Story Jan. 29 - I-Mab: After announcing a pipeline restructure earlier in the month, I-Mab’s has reduced its workforce by around 27%. Story Jan. 28 - Zentalis Pharmaceuticals: In hopes of ...

Zentalis estimates that about half of PROC patients overexpress Cyclin E1 based on its proprietary immunohistochemistry cutoff. As of the January 13, 2025 data cutoff, the safety and tolerability ...

SAN DIEGO, March 15, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 ...

Zentalis reports updated DENALI trial results for azenosertib in platinum-resistant ovarian cancer, showing 6.3 months median duration of response. Updated median duration of response (mDOR) of 6. ...

Explore Zentalis Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ZNTL. FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies ...

Languages: English. President Donald Trump and New York Governor Kathy Hochul are set for a White House meeting on Friday to discuss a major pipeline project that New York has held up for years.

Immunome ( (IMNM) ) has shared an announcement. Immunome, Inc. has secured a pivotal asset purchase from Zentalis Pharmaceuticals, acquiring a license for innovative antibody-drug conjugate ...

After hours: March 17 at 5:40:27 PM EDT Loading Chart for ZNTL ...

On Wednesday, Zentalis Pharmaceuticals (NASDAQ:ZNTL) saw its price target adjusted by H.C. Wainwright, with the firm reducing the ...

In this episode, we look at the work of the Pipeline Industries Guild, in facilitating connections and learning for pipeliners of all kinds in the UK. Featured guests: Kate Lazenby, Executive Director ...